Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Research Study to Investigate How Well Semaglutide Works in People Living With Heart Failure and Obesity

ClinicalTrials.gov ID: NCT04788511

Public ClinicalTrials.gov record NCT04788511. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 12, 2026, 11:47 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Effect of Semaglutide 2.4 mg Once Weekly on Function and Symptoms in Subjects With Obesity-related Heart Failure With Preserved Ejection Fraction

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will look at how the participants daily life is affected by their heart failure. The study will also look at the change in participants body weight from the start to the end of the study. This is to compare the effect on heart failure symptoms and on body weight in people taking semaglutide (a new medicine) to people taking "dummy" medicine. Participants will either get semaglutide or "dummy" medicine - which treatment participants get is decided by chance. Participants will need to take 1 injection once a week. The study medicine is injected with a thin needle in a skin fold in the stomach area, thigh or upper arm. During the study participants will have talks with the study staff about healthy lifestyle choices including healthy food and physical activity. The study will last for approximately 59 weeks. Participants will have 11 clinic visits and 1 phone call with the study doctor. Women: Women cannot take part if they are pregnant, breast-feeding or plan to become pregnant during the study period.

Study identification

NCT ID
NCT04788511
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
529 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 16, 2021 (Actual)
Primary completion
Apr 18, 2023 (Actual)
Completion
Apr 18, 2023 (Actual)
Last update posted
Dec 5, 2025

2021 – 2023

United States locations

U.S. sites
50
U.S. states
24
U.S. cities
44
Facility City State ZIP Site status
Eastern Shore Rsrch Inst, LLC Fairhope Alabama 36532 —
National Heart Institute Cal Beverly Hills California 90211 —
Keck Medical Center of USC - Outpatient Clinic Los Angeles California 90033 —
Lundquist Inst-Biomed Innovtn Torrance California 90502 —
Jacksonville Ctr For Clin Res Jacksonville Florida 32216 —
First Coast Cardiovascular Institute Jacksonville Florida 32257 —
Baptist Heart Specialists_Jacksonville Jacksonville Florida 32258 —
CV Res Ctr of S Florida Miami Florida 33173 —
Endeavor Health Clinical Operations-NCH Arlington Heights Illinois 60005 —
University of Chicago Medicine Chicago Illinois 60637 —
Endeavor Health Glenbook Hosp Evanston Illinois 60201 —
Northwestern University_Chicago_0 Evanston Illinois 60208 —
Chicago Medical Research LLC Hazel Crest Illinois 60429 —
Ascension St. Vincent Medical Group Indianapolis Indiana 46260 —
University of Iowa Iowa City Iowa 52242 —
University of Kansas Medical Center_Kansas City Kansas City Kansas 66160 —
Cotton-O'Neil Heart Center Topeka Kansas 66606 —
The Research Group of Lexington LLC Lexington Kentucky 40503 —
Baptist Health Louisville Louisville Kentucky 40207 —
Baptist Health Madisonville, Inc Madisonville Kentucky 42431 —
Grace Research, LLC Bossier City Louisiana 71111 —
Heart Clinic of Hammond Hammond Louisiana 70403 —
Grace Research, LLC_Shreveport Shreveport Louisiana 71105 —
Louisiana Heart Center_Slidell Slidell Louisiana 70458 —
Louisiana Heart Center Slidell Louisiana 70458 —
Ascension Saint Agnes Heart Ca Baltimore Maryland 21229 —
John Hopkins Hospital Baltimore Maryland 21287 —
Henry Ford Hospital Detroit Michigan 48202-2689 —
Mayo Clinic Rochester Rochester Minnesota 55902 —
Univ of Mississippi Med Ctr Jackson Mississippi 39216 —
Saint Luke's Hospital of Kansas City Kansas City Missouri 64111 —
St Louis Heart & Vascular, P.C. St Louis Missouri 63136 —
Bryan Heart Lincoln Nebraska 68506 —
CHI Health Clinic Cardiology (CUMC - Bergan Mercy) Omaha Nebraska 68124 —
St Francis Hospital Lindner Research Center Greenvale New York 11548 —
NY Presbyt Hosp-W Cornell Med New York New York 10021 —
Rochester General Hospital Rochester New York 14621 —
Wake Forest School of Medicine Winston-Salem North Carolina 27157 —
Lindner Center,Christ Hospital Cincinnati Ohio 45219 —
Abington Memorial Hospital Abington Pennsylvania 19001 —
Hospital of the University of Pennsylvania Philadelphia Pennsylvania 19104 —
Hospital of University of Pennsylvania Philadelphia Pennsylvania 19104 —
Medical Univ of South Carolina_Charleston_0 Charleston South Carolina 29425 —
Sanford Health_Sioux Falls Sioux Falls South Dakota 57117 —
University of Texas Southwestern Medical Center Dallas Texas 75390 —
University of Utah School of Medicine Salt Lake City Utah 84132 —
Cardiology Consultants of Danville Inc. Danville Virginia 24541 —
Virginia Heart Falls Church Virginia 22042 —
Sentara Health Research Center Norfolk Virginia 23507 —
Virginia Commonwealth University Health System Richmond Virginia 23298-5058 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 96 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04788511, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 5, 2025 · Synced Oct 12, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04788511 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →